Rosebank Industries, a relatively new player in the industrial sector, is adopting an acquisition strategy that distinguishes it from traditional conglomerates. Founded two years ago with a market capitalization of £3.6 billion, Rosebank focuses on acquiring underperforming businesses with potential for margin and cash flow improvements, then selling them at a higher valuation. This model diverges from the typical buy-and-hold approach of peers such as Diploma, Bunzl, Halma, and Judges Scientific, which aim to build long-term, larger groups through adding quality businesses in similar or adjacent markets.
Rosebank’s approach mirrors private equity tactics rather than the conventional conglomerate method. The company targets turnaround opportunities, employing measures such as exiting low-margin sectors, price adjustments, factory closures, management incentives, and capital investments to enhance profitability. Management aims to create shareholder value within three to five years of acquisition.
Since its June debut on the FTSE 250 index, Rosebank has delivered encouraging financial results. The group, managed by former Melrose executives, reported first-half adjusted operating profit of $110 million (£81.4 million), exceeding expectations. It projects full-year profits to surpass the consensus forecast of $294 million, a target reiterated following a prior July statement. Rosebank has completed three acquisitions since its 2024 listing as a cash shell, reinforcing its buy, improve, sell strategy.
Free cash flow for the first half stood at $88 million after $25 million of restructuring expenses, while net debt reached $1.07 billion, representing a leverage ratio of 2.4 times. Shares are trading at a forward price-to-earnings ratio of 18 times, slightly below the sector average of 19 times, according to Barclays.
Elsewhere in the industrial sector, Ashmore, a FTSE 250 specialist asset manager focusing on emerging markets, reported a 7 percent decline in adjusted net revenue to £136 million for the year. This was largely driven by a significant drop in performance fees, which fell by £8.8 million to £1.4 million amid reduced private equity realisations. The decline weighed on adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), which fell 32 percent to £35.7 million, well below consensus estimates. Operating expenses rose 8 percent to £107 million, partly attributable to increased staff costs. However, Ashmore’s reported pre-tax profit increased 17 percent to £127 million, supported by a doubling of seed capital gains to £82.5 million. Assets under management grew 13 percent to $54 billion (£39.9 billion), supported by net inflows of $2.7 billion.
In the lime and minerals sector, SigmaRoc reported a 14 percent increase in pre-tax profit to £45 million, with revenues rising 3 percent to £523 million. The company attributed the improved earnings to price increases offsetting a 3 percent decline in sales volumes. Revenue growth was strongest in its industrial and environmental segments, while the construction division faced headwinds amid slowing housebuilding, a trend partly linked to geopolitical tensions such as the ongoing conflict in Iran. Cost efficiencies, including the internalization of the UK haulage operations, contributed to a 200 basis point increase in the company’s EBITDA margin, now standing at 25.1 percent. SigmaRoc also expanded its portfolio with the €110 million (£95 million) acquisition of Dolomitas, a Lithuanian dolomite producer, as part of its "buy and build" strategy. The company’s shares currently trade at approximately 12 times projected next-year earnings.